Dr. Omer Junaidi, MD

Dr. Junaidi practices at Methodist Hospital (TX) in San Antonio, Texas.

Dr. Junaidi's NPI, 1457435331, was assigned on October 25, 2006. Dr. Junaidi graduated from Dow University of Health Sciences in 2000. Dr. Junaidi holds Texas license P3363.

Dr. Junaidi's primary practice is Methodist Hospital (TX), at 7700 Floyd Curl Dr, San Antonio, TX 78229 in Bexar County. The practice phone is (210) 575-4000.

Dr. Junaidi's primary practice is Methodist Hospital (TX) in San Antonio, Texas. Dr. Junaidi is also affiliated with Methodist Hospital. The medical group on file is Methodist Healthcare System. Dmand AI also links Dr. Junaidi to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Junaidi practices, 2 sites in all. Vendor and product names are available with a free account.

Transplant hepatology is Dr. Junaidi's primary specialty in the NPI Registry, under taxonomy code 207RT0003X. Dmand AI has Dr. Junaidi's licenses on file in 2 states: Texas and Missouri.

Dmand AI lists cirrhosis of the liver, fatty liver and upper GI endoscopy among the conditions Dr. Junaidi treats.

CMS data shows 177 Medicare services from Dr. Junaidi across 4 procedure codes in 2024, for 129 Medicare patients. Medicare paid $12,363 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 129 Medicare patients who saw Dr. Junaidi in 2024. The largest group is 65 to 74, with 63 patients. 75% of them have high blood pressure, and 67% have high cholesterol. 16% are also on Medicaid. Their average risk score is 2.92, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Junaidi's median patient age at 64, with 47% women.

In 2024, Dr. Junaidi wrote 244 Medicare Part D claims for 85 patients. 86% of them were for generic drugs. CMS names the drug for 64 of them, across 4 drugs with 11 or more claims each, at $2,478 in total drug cost. In 2023, CMS named 165 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Junaidi for performance year 2024, reported as part of a group. Dr. Junaidi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 17 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Junaidi, more than 48% of the clinicians it reports for that procedure.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 4 papers to Dr. Junaidi, published from 2004 to 2009. The most frequent topics are Biomarkers, Tumor, Blotting, Western and Carcinoma, Hepatocellular. Dr. Junaidi's most frequent co-authors are Eldad Shaul Bialecki, MD, Paola G. Blanco, MD and Sunil A. Sheth, MD.

Dmand AI links Dr. Junaidi to 1 clinical trial. Conditions studied include Hepatitis and Liver Diseases.

CMS Open Payments shows 41 general payments to Dr. Junaidi from 10 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 100% of the total. Intercept Pharmaceuticals, Inc. paid the most, $289.

Dr. Junaidi graduated from Dow University of Health Sciences in 2000. Dr. Junaidi is a member of ACG.

Dr. Junaidi is in network with 23 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.